BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4398008)

  • 1. The influence of propranolol, INPEA, iproveratril and some 1-naphthylethylamine derivatives on the myocardial phosphorylase activity.
    Robak J; Gryglewski R
    Biochem Pharmacol; 1970 Apr; 19(4):1221-7. PubMed ID: 4398008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the mechanism of action of INPEA, iproveratril and oxyfedrin].
    Bosse JA; Schaum E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):221-2. PubMed ID: 4390696
    [No Abstract]   [Full Text] [Related]  

  • 3. [Modified method for the testing of surface anesthesia on the rabbit cornea, using cocaine, procaine, propranolol, alprenolol, INPEA and verapamil].
    Bartsch W; Knopf KW
    Arzneimittelforschung; 1970 Aug; 20(8):1140-3. PubMed ID: 5536515
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of INPEA, pindolol and propranolol on the chronotropic and metabolic responses to -adrenergic stimulation in intact rats.
    Robak J; Gryglewski R
    Biochem Pharmacol; 1971 Oct; 20(10):2749-58. PubMed ID: 4398866
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of beta-receptor blocking agents and related substances on the excitation, contraction and energy metabolism of myocardium fibers].
    Fleckenstein A; Döring HJ; Kammermeier H
    Klin Wochenschr; 1968 Apr; 46(7):343-51. PubMed ID: 4386795
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the influence of beta-receptor blocking agents, iproveratril, quinidine and reserpine on the effect of k-strophanthin in the guinea pig heart].
    Fratz R; Greeff K; Wagner J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):196-206. PubMed ID: 4233000
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the myocardial depressant effect of KL 255: a beta adrenergic receptor antagonist.
    Pendleton RG; Petta JM; Hahn RA
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):75-87. PubMed ID: 4394700
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-adrenolytic effect as well as influence of INPEA and MJ 1999 on refractory period and contractility of the guinea pig atrium].
    Wagner J; Schümann HJ
    Experientia; 1970; 26(2):163-4. PubMed ID: 4391796
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of interaction of antiarrhythmic drugs and beta-blocking agents on the isolated rabbit heart.
    Bertaccini G; Impicciatore M; Visioli O; Malagnino G
    Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):209-17. PubMed ID: 5709785
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of Verapamil on the metabolism of myocardium].
    Haas H; Gokel M
    Arzneimittelforschung; 1970 May; 20(5):647-55. PubMed ID: 4393245
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative effects of sotalol and propranolol on contractility of papillary muscles and adenyl cyclase activity of myocardial extracts of cat.
    Parmley WW; Rabinowitz B; Chuck L; Bonorris G; Katz JP
    J Clin Pharmacol New Drugs; 1972 Apr; 12(4):127-35. PubMed ID: 4401703
    [No Abstract]   [Full Text] [Related]  

  • 13. Antioxytocin activity of propranolol, INPEA and their optical isomers on the isolated rat uterus.
    Saini RK; Sharma PL
    Eur J Pharmacol; 1971 May; 14(4):399-401. PubMed ID: 4400536
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of an adrenergic beta receptor blockader (D(-)INPEA) on various functional parameters of the rabbit heart].
    Arrigo L; Macrì I; Rigon-Macrì P
    Boll Soc Ital Biol Sper; 1971 Oct; 47(20):647-50. PubMed ID: 4401207
    [No Abstract]   [Full Text] [Related]  

  • 15. [The inherent contractility-reducing effect of various beta-adrenolytic agents on a heart-lung preparation in the dog].
    Schmidt HD; Schmier J
    Z Kreislaufforsch; 1967 Nov; 56(11):1137-50. PubMed ID: 5595876
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-receptor blocking and cardiodepressant actions of 2-nitrilophenoxypropanolamines.
    Mylecharane EJ; Raper C
    Eur J Pharmacol; 1971 Sep; 16(1):14-20. PubMed ID: 4400509
    [No Abstract]   [Full Text] [Related]  

  • 17. The reversal of phenoxybenzamine-produced alpha-adrenoceptor blockade by the isomers of propranolol and INPEA.
    Davis WG
    J Pharm Pharmacol; 1971 May; 23(5):332-8. PubMed ID: 4396976
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of beta-adrenergic blocking activity of DCI, H56-28, ICI50172, LB46, methoxamine, MJ1999 and propranolol in the blood perfused canine papillary muscle preparation.
    Hashimoto K; Endoh M; Tamura K; Taira N
    Experientia; 1970; 26(7):757-9. PubMed ID: 4393455
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.
    Mazurkiewicz-Kwilecki IM; Romagnoli A
    J Pharm Pharmacol; 1970 Mar; 22(3):235-7. PubMed ID: 4399498
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of post-trial injection of beta adrenergic blocking agents on a conditioned reflex in rats.
    Merlo AB; Izquierdo JA
    Psychopharmacologia; 1971; 22(2):181-6. PubMed ID: 4399389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.